
Cofounder at @fodzyme, Kiwi Bio (@ycombinator S21) — interested in plants, sugars, microbes, and humans. Previously @auggihealth @HarvardChanSPH @cornell_tech
London, England
Joined February 2009
- Tweets153
- Following1.2K
- Followers248
- Likes853
David Hachuel, MPH retweeted
Today we’re opening our structure-free AI drug discovery model for all to use!
Ptarmigan-1 predicts which small molecules bind a protein, and where, without building a 3D protein structure. It learns from multiple kinds of data, including measurements of proteins at work inside living human cells.
This is the culmination of a long and winding path to get here
In my first week of grad school, I sat in a lecture hall where generations of chemists had trained and Nobel Prizes hung on display. One of the most accomplished chemists in the world introduced us to the word “undruggable,” describing targets that so many had given up on.
I remember sitting there feeling so indignant. Of course all targets are impossible to drug until the right technology lets you drug it.
Thankfully I found my people in @jaybradner's lab, where the T-shirts said “nothing is undruggable”, and got to work
We focused on gene regulators there, proteins that control which genes turn on and off and can drive cancer. Most are poorly structured, making them difficult targets for traditional tech that focus on a well-defined binding pocket.
Gene regulators are not the only disordered proteins though. Roughly 40% of the human proteome has significant disorder, and these targets remain out of reach while discovery for structured proteins gets faster every year.
With Ptarmigan-1, we’re giving researchers a way to search for molecules against these targets without first having to solve their structure.
I’m grateful to the team and supporters that brought us here. Now we get to see what the community does with it.
Try it and tell us what you think. Link below.
David Hachuel, MPH retweeted
After co-inventing ChatGPT, I kept asking myself: why have superhuman chat models not led to AGI?
I’ve spent the last 2 years in stealth building a new way to train models (RLCD), and a new type of frontier AI model that we are releasing today: Jev
• 20-200x faster
• 40-400x cheaper (w/ output tokens free)
• Frontier composable intelligence optimized for decisions
AFAICT the shortest path to AI-based economic revolution
David Hachuel, MPH retweeted
Introducing our Trusted Person network powered by our new Instinct-to-Instinct communication protocol. Your Instinct can now talk to other Instincts to coordinate plans on your behalf.
Getting people together often involves a lot of back-and-forth: finding a time, working out the details, and following up when plans change. Instincts can now work with each other to help handle that coordination.
For example:
- Coordinating plans with your spouse
- Planning a weekend trip with friends, including dates and arrival times
- Scheduling time with colleagues and other collaborators
- Hosting events with 10s or 100s of people
- Organizing recurring plans like tennis, book clubs, or weekly dinners
Disclaimer: Your Instinct will only be able to communicate with those in your Trusted Person network. This is the group of people who are closest to you:
- Spouse
- Older children and parents
- Colleagues and trusted professional relationships
- Small local businesses
The Trusted Person network is currently available to our early access group and will be slowly rolled out across the user base over the next 24-48 hours.
one of the best signs of intelligence is definitive range.
e.g. someone who can have a deeply serious intellectual convo & then immediately make a fart joke or say something completely regarded.
you rarely ever encounter ppl who can effortlessly move between profound shit & the absurd. this is why the south park guys are geniuses.
Sold out in 5 hours 🤯
If you missed it, we're giving away 3 Raycast keyboards.
To enter:
1️⃣ Follow @raycast and @nuphystudio
2️⃣ Repost this tweet
3️⃣ Reply with your favorite shortcut
We'll pick 3 winners on Monday. Good luck!
David Hachuel, MPH retweeted
Introducing GlucoFM, a lightweight, self-supervised continuous glucose monitoring foundation model that separates metabolic baselines from transient spikes, producing transferable representations and setting new performance standards across diverse metabolic prediction tasks, such as diabetes risk assessment, insulin resistance, and post-prandial glycemic response.
Learn more →goo.gle/4cbfigr
David Hachuel, MPH retweeted
Introducing Bot Mode for Hermes Desktop.
Your agent profiles become a series of named Bots. Each Bot has its own role, model, memory, skills and profile picture; Bots can use any model and even communicate with each other.
Build a specialist Bot once to use it forever.
An hour of agentic computer use may now be cheaper than an hour of human labor:
Computer-use agent: $6-8
Offshore outsourced talent: ~$10
US talent: $30-45
"The math only gets better - inference keeps getting cheaper, and open-source models are getting good enough for a growing share of these workflows."
The data on computer-use agents, from @fabrisera2000, @seema_amble, and @zephratic: a16z.news/p/can-agents-use-a…
Durante las misiones de esta pasada noche, militares de la #UME han completado en La Adrada y Piedralaves estas actuaciones:
💦 Ataque directo a las llamas
🔥 Fuego técnico para eliminar combustible
🔎 Vuelo de drones para vigilancia de perímetro
#IFBurgohondo
David Hachuel, MPH retweeted
I'm a cardiologist. Everyone is sharing this study as a skin story. They're burying the part that matters.
Scientists took the aorta of a 75-year-old donor, applied a single engineered enzyme, and stripped away more than 70% of the molecular damage — bringing it down to the levels you'd see in a 30-year-old artery.
Published five days ago in Nature Communications. Revel Pharmaceuticals, with Calico and the University of Colorado.
Here's what they erased.
Sugar reacts with proteins in your body the same way heat browns bread — slowly, over a lifetime. It leaves behind a residue called CML, the most abundant advanced glycation end product in aging tissue. It welds itself onto collagen and elastin in your skin, your eye lens, and your arterial walls.
Two things follow. Your arteries stiffen. And CML latches onto a receptor called RAGE, which drives chronic inflammation — the exact fire I've been writing about for months as the engine of heart disease.
Since the 1980s this damage was considered permanent. Your body has no enzyme to remove it. Every existing approach only slows new damage from forming. Nothing touched what was already there.
So they built an enzyme that doesn't exist in nature. They screened 45,000 protein structures, then ran five rounds of directed evolution across more than 500 million variants until they had CMLase — a molecular lawnmower that oxidizes the CML off the protein and restores the original, healthy lysine underneath.
Not patched. Reversed.
Over 70% cleared from elderly arterial tissue. Over 55% from elderly skin — below the levels found in 31-year-old skin. 45-78% in lens proteins. The CEO said they expected 20% and were floored.
Arterial stiffness drives systolic hypertension, heart failure, and stroke, and I have no drug that reverses it. I can slow the process. I cannot undo it. This paper says undoing it may be possible.
The caveats are real and I won't skip them. This was done on donated tissue in a dish, not in a living person. No functional data yet — we don't know if that artery got measurably more elastic. Delivering a large enzyme deep into human tissue is a hard, unsolved problem. Clinical trials are years away.
But something considered permanent for forty years just came off human tissue.
We spent a century learning to slow aging. Someone finally figured out how to erase it.
Thank you @theallinpod @friedberg @chamath @pesottas
Friedberg: New study shows enzyme reverses skin age from 70+ years to 31
Chamath: That’s a $2T market.
Did Scientists Just Discover How to Reverse Skin Aging!?
“CML is kind of the predominant molecule that gets formed in this extracellular matrix that's driving aging, and nothing breaks it down.
So these scientists set out to try and create an enzyme, an enzyme is a protein that breaks something down, that can break down CML.
And so these guys kind of went out and they took the target, which is CML, and tried to figure out, ‘Okay, how do we actually degrade CML, clear that extracellular matrix, and reverse aging?’
They started to test it on the proteins that we would find in our body, casein, collagen, retinal proteins, which are in your eye, hemoglobin, and they were able to get rid of 52 to 97% of the CML, just degrade it away.
And then they found several sites where they were able to degrade over 90%.
And then they took actual human skin from elderly patients that had donated their skin, and they put this enzyme onto that skin, and they were able to eliminate 55% of the CML on the skin, basically reverse the skin's age down to the age of a 31-year-old, this is from greater than 70-year-old patients, just by putting this enzyme on the skin.
And so it's kind of a groundbreaking demonstration of combination of AlphaFold, what's called directed evolution, where you change the order of the DNA that changes the structure of the protein to test different proteins, do high throughput screening, and ultimately make a novel protein that doesn't exist in nature today that can do something pretty profound for human health.”
Chamath:
“It will be a trillion-dollar market. If you can create a cream…”
Friedberg:
“I mean, dude, if you could put this enzyme literally on your skin and have it absorb in…”
Chamath:
“Game over. That alone is $2 trillion.”
🚨 Press alert!
Sazabi is proud to be included in @TechCrunch's round-up of top companies from the YC P26 batch!
Congratulations to all the incredible founders and companies from our batch. We are honored to be building alongside you.
🔗 Check it out: techcrunch.com/2026/06/18/th…
David Hachuel, MPH retweeted
Prepare for takeoff. ✈️ Flight simulator is now available globally on web to all users. goo.gle/4fBYnWO
We've recently added many our most powerful professional desktop features to web. Elevation profiles, new import types, but there's always been one other feature you've been asking us to add to the web version of Google Earth, just for fun...
Where will you fly? Share your best maneuvers, views, and flyovers with us!
Everyone is vibe coding. I tried vibe-woodworking.
I asked ChatGPT for IKEA-like bench plans, bought some 2x4s, and built it over a weekend.
It actually turned out great. Smells like pine too.
This was too fun not to share, so I built SlopAndLumber for you to try it too. ↓
David Hachuel, MPH retweeted
NEW CASE STUDY from @diffuse_bio: up to 1000x tighter protein binding in 1 week -- unprecedented performance and speed 🧵
David Hachuel, MPH retweeted
MIT engineers show they can accurately measure blood glucose by shining near-infrared light on the skin. news.mit.edu/2025/noninvasiv…
David Hachuel, MPH retweeted
Update: we can now do affinity maturation in as little as 1 week with RamaX Opt from @diffuse_bio!
To our knowledge, this is the fastest affinity maturation method available, outperforming even the most advanced existing experimental and AI approaches 🧵
David Hachuel, MPH retweeted
How AI empowered Paul Conyngham to create a custom mRNA vaccine to cure his dog’s cancer when she had only months to live. The first personalized cancer vaccine designed for a dog:
David Hachuel, MPH retweeted
AI performance scales with data 💪
Thrilled to launch RamaX: our platform for ultra-fast, accurate, and sensitive screening of massive binder libraries (from 1K to 1B minibinders, VHHs, or scFvs) in just 1-2 weeks.
This method has been an absolute game-changer for us at @diffuse_bio. Internally, we’ve completely switched from yeast display to RamaX for screening our designs. We’re also using RamaX to generate enormous datasets to train our protein generative models. 🧵 1/



































